Healthcare marketers today have no shortage of data, including claims, scripts, engagement signals, patient journeys, and more. So, access isn't a bottleneck. The real question is whether that data can actually shape strategy before a campaign launches, rather than just explain what happened after it runs.
DeepIntent Helix™ closes that gap. It takes fragmented datasets that aren’t prepared for use and both connects them and turns them into real commercial intelligence, helping agencies and brands ask sharper questions and get faster, smarter answers. And it does so on a foundation built from more than a decade of healthcare and media data expertise and millions of campaigns.
The result is data you can act on before a single dollar is spent.
The Old Way vs. The Helix Way
Before Helix, commercial insights in healthcare marketing looked like:
• Stitching together syndicated reports and lagging indicators.
• Waiting until after a campaign is over to understand what worked.
• Making educated guesses about market dynamics without reliable prescribing data.
• Operating in silos, with media, field, and messaging rarely aligned around the same insight.
With Helix, that changes:
• Intelligence is available before campaigns launch, not after.
• Data is already privacy-compliant and tied to HCP identity (no wrangling required).
• Pre-built queries and tools jumpstart strategic analysis and accelerate time-to-value.
• Agencies can build proprietary, white-labeled analyses.
• Strategy is proactive, uncovering whitespace, risks, and opportunities before they're obvious.
Three Commercial Insights Helix Unlocks Right Now
Helix supports a broad range of commercial use cases. Here are three that demonstrate the shift from reactive reporting to proactive strategy.
1. Steal Market Share: See Exactly Where You're Losing, and Why
Before Helix: You knew competitors existed but couldn't identify which specific HCPs in your target audiences were actively writing their drugs, or where.
With Helix: You can see exactly which HCPs in your audiences are prescribing competitor products, broken down by location and market segment. Instead of broadly targeting a geographic region, you can prioritize the specific physicians writing a competitor's drug in the zip codes that matter most and tailor your messaging accordingly.
Impact: This enables agencies to help brands augment strategies with collateral specific to where your brands can win.
2. Win New Business: Discover the Audience You Didn't Know Existed
Before Helix: HCP targeting was built on what you already knew, like existing customer lists, prior campaign audiences, and conventional segmentation.
With Helix: You can pull competitive insights to find genuine whitespace in your market. Imagine identifying 10,000 HCPs who are actively diagnosing your indication but have never written your drug, physicians who are treating exactly the patients you care about but remain entirely off your radar. Helix surfaces that universe so you can reach them before your competitors do.
Impact: This is what transforms an agency from an execution partner into an indispensable strategic one. Rather than simply responding to a client brief, you can walk in with market intelligence and revenue opportunities the brand had never considered. That's the kind of edge that wins pitches and retains clients.
3. Identify Brand Risks: Sustain Active Treatment
Before Helix: Adherence was a lagging metric. You found out patients were going off therapy once they already had.
With Helix: Prescribing and behavioral signals can flag patients who are at risk of discontinuing therapy before it happens. Teams can identify the HCPs whose patients are most likely to lapse, then align media and messaging to support adherence at exactly the right moment, with the right audience, in the right channel. Helix empowers you to protect revenue and patient outcomes by intervening proactively.
Impact: Adherence is a multi-billion dollar problem for pharma. Brands spend large amounts of time and investment messaging HCPs and their patients at critical clinical milestones. These efforts have failed if the script is never filled. As an agency, identifying these risks can help brands sustain active treatments, keep patients on therapy, and drive positive outcomes.
Why the Foundation Matters: AI Is Only as Good as Its Input
The use cases above are only possible because of what's underneath them. Helix is built on more than a decade of healthcare data expertise, shaped by millions of campaigns. That history means DeepIntent knows how to take raw, fragmented data and make it analysis-ready, AI-ready, and tied to HCP identity in a fully privacy-safe environment.
It's well understood now that AI output is only as good as its input. Helix's input is the gold standard. Plus, the infrastructure for data ingestion, privacy compliance, and clean room environments is already built in. Teams are spending less time wrangling data and more time acting on it.
What This Series Covers
This is part 1 of a five-part series exploring how Helix sharpens and accelerates the full marketing lifecycle. Upcoming installments will go deeper on:
- Helix for Strategy & Planning
- Helix for Audiences
- Helix for Activation
- Helix for Reporting & Analytics
The teams winning in healthcare marketing today are the ones empowered to act on data before their competitors. Helix is how you get there: from fragmented signals to a clear picture of where to go, who to reach, and what to say before anyone else figures it out.
Ready to see what Helix can uncover for your brand? Learn more here.
.png)
